Investments fürs neue Jahr gesucht? Informieren Sie sich jetzt über interessante Anlagemöglichkeiten in 2022!-w-
06.12.2021 11:58

Zacks.com featured highlights include: Target, Olin, Callon Petroleum, Cboe Global Markets and Nutrien

Folgen
Werbung
For Immediate ReleaseChicago, IL – December 6, 2021 – Stocks in this week’s article are Target Corporation TGT, Olin Corporation OLN, Callon Petroleum Company CPE, Cboe Global Markets, Inc. CBOE and Nutrien Ltd. NTR.Add These 5 Strong Sales Growth Stocks to Your Portfolio NowWhen it comes to picking stocks, investors often opt for complex investment strategies to generate higher returns. But with ever-changing market dynamics, this may not yield desired results every time. So, using conventional strategies based on key fundamentals to choose stocks is always wise.One such strategy is sales growth. Maintaining steady sales growth is the key to survival for any business. Sales growth remains a vital measure for any corporate house, as it is important for growth projections and strategic decision-making.Hence, when companies incur losses for a temporary period, they are valued based on their revenues, as top-line growth (or decline) is usually an indicator of a company’s future earnings performance. Also, in contrast to price to earnings and price to book value ratios, which can turn negative and cease to be relevant, price-to-sales (P/S) ratio is available even for companies that have hit choppy waters.Further, profits and book value are primarily influenced by several factors. However, management has limited opportunities to manipulate sales, which further underscores the importance of P/S ratio. Therefore, P/S ratio can serve as a more reliable metric for stock valuation.Focusing solely on sales growth is, however, not enough. Consideration of a company’s cash position along with its sales can be a more dependable strategy. Significant cash in hand and steady cash flow give a company more flexibility with respect to business decisions and investments.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/1834936/add-these-5-strong-sales-growth-stocks-to-your-portfolio-nowDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.About Screen of the WeekZacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.Strong Stocks that Should Be in the NewsMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.Follow us on Twitter:  https://www.twitter.com/zacksresearch Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: www.Zacks.com Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Investor Alert: Legal Marijuana Looking for big gains?Now is the time to get in on a young industry primed to skyrocket from $13.5 billion in 2021 to an expected $70.6 billion by 2028.After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could kick start an even greater bonanza for investors. Zacks Investment Research has recently closed pot stocks that have shot up as high as +147.0%.You’re invited to immediately check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.Today, Download Marijuana Moneymakers FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Target Corporation (TGT): Free Stock Analysis Report Cboe Global Markets, Inc. (CBOE): Free Stock Analysis Report Olin Corporation (OLN): Free Stock Analysis Report Callon Petroleum Company (CPE): Free Stock Analysis Report Nutrien Ltd. (NTR): Free Stock Analysis Report To read this article on Zacks.com click here.
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Nutrien (Ex Potash Agrium)

  • Relevant
    1
  • Alle
    3
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Nutrien (Ex Potash Agrium)

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
10.01.2022Nutrien (Ex Potash Agrium) OverweightBarclays Capital
04.01.2022Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
08.12.2021Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
11.08.2021Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
10.08.2021Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
10.01.2022Nutrien (Ex Potash Agrium) OverweightBarclays Capital
04.01.2022Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
08.12.2021Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
11.08.2021Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
10.08.2021Nutrien (Ex Potash Agrium) OutperformRBC Capital Markets
10.04.2018Nutrien HaltenDZ BANK
26.01.2017Potash HoldHSBC
28.11.2016Potash HoldHSBC
21.11.2016Agrium HoldStandpoint Research
31.10.2016Potash NeutralGoldman Sachs Group Inc.
09.12.2016Potash UnderperformCowen and Company, LLC
19.04.2016Potash UnderweightBarclays Capital
21.08.2013Potash verkaufenHSBC
07.08.2012Agrium underperformNATIONAL-BANK
05.06.2012Potash underperformNATIONAL-BANK

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nutrien (Ex Potash Agrium) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen

JETZT LIVE!

Viele Ansätze haben eine begrenzte Halbwertzeit im Trading. Sie funktionieren eine Weile, können dann aber nicht mehr erfolgreich angewendet werden. Im Trading-Seminar um 18 Uhr wie sie Kurzfrist-Trends erfolgreich traden.
Schnell noch reinklicken!
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX verabschiedet sich höher -- Valneva-Vakzin neutralisiert wohl Omikron-Variante -- PUMA verdoppelt EBIT 2021 -- SUSE übertrifft Erwartungen -- BMW, VW, thyssenkrupp im Fokus

EZB-Protokolle: Währungshütern bereitet Szenario hartnäckiger Inflation Sorge. Travelers übertrifft Erwartungen deutlich. Erstarkendes Primark-Geschäft sorgt für Zuversicht bei AB Foods. Brookfield hält nach erster Frist 71 Prozent an alstria office. Lagarde: Eine rasche Zinswende wie wohl bald in USA kein Thema für EZB. Sony: Activision-Spiele bleiben nach Microsoft-Deal verfügbar.

Umfrage

Haben Sie Verständnis für Menschen, die gegen die Corona-Politik demonstrieren?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln